Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Ropivacaine × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 5 Pain, Postoperative 2 Urinary Bladder Neoplasms 1 Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Agnosia 1

Interventions

Lidocaine 2 Ketorolac 2 Acupuncture Therapy 2 Transcutaneous Electric Nerve Stimulation 1 Surveys and Questionnaires 1 Ropivacaine 1 Oxycodone 1 Ketamine 1 Epinephrine 1 Diazepam 1 Clonidine 1 Anesthesia, Local 1 Acupressure 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡